Novel delivery systems in contraception

British Medical Bulletin

Volumn 56, Issue 3, 2000, Pages 739-748

  Lähteenmäki, Pekka ^a   Jukarainen, Harri ^a  

^a Oy Leiras Finland Ab   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DIMETICONE; ELCOMETRINE; ETONOGESTREL; FOLLITROPIN; LEVONORGESTREL; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; NANDROLONE DERIVATIVE; PROGESTERONE; TESTOSTERONE; TRESTOLONE; UNCLASSIFIED DRUG;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG IMPLANTATION; DRUG TARGETING; FAMILY PLANNING; HORMONAL CONTRACEPTION; HUMAN; MICROENCAPSULATION; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; VAGINA RING;

ADULT; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, MALE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; IRON; LEVONORGESTREL; MALE; MENSTRUATION DISTURBANCES; PATIENT SATISFACTION; PROGESTERONE;

EID: 0034515132     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142001903328     Document Type: Review

References (27)

1. Fertility control in women with a progestin released in microquantities from subcutaneous capsules
2. Implanon - A review of clinical studies
3. Measuring compliance among oral contraceptive users
4. Contraception with NORPLANT® implants
5. Contraception with two levonorgestrel rod implants: A five year study in the United States and Dominican Republic
6. Levonorgestrel concentrations during use of a levonorgestrel rod (LNG ROD) implants
7. Insertion and removal of Implanon®
8. The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen and progesterone levels
9. The pharmacodynamics and efficacy of Implanon® - An overview of the data
10. Progestasert: A uterine therapeutic system for long-term contraception: Philosophy and clinical efficacy
11. Levonorgestrel-releasing intrauterine device
12. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices
13. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use. A randomized comparative trial
14. Recovery of fertility after use of levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device
15. Early chorionic activity in women bearing inert IUD. Copper IUD and Levonorgestrel-releasing IUD
16. Ovarian function during use of a levonorgestrel-releasing IUD
17. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levogestrel-releasing intrauterine device
18. Levonorgestrel releasing intrauterine device in the treatment of menorrhagia
19. Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy
20. Continuation rates among injectable contraceptive users
21. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill
22. Evaluation of four different contraceptive vaginal rings: Steroid serum levels, luteal activity, bleeding control and lipid profiles
23. Task on long-acting systemic agents for fertility regulation special programme of research development and research training in human reproduction: Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial. I. Contraceptive efficacy and side effects
24. Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginally
25. Pharmacokinetics and pharmacodynamics of 7α-methyl-19-nortestosterone after intramuscular administration in healthy men